author-photo

Robert Hollingsworth

Pfizer

2

Papers

2

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

First-in-human, phase I study of PF-06753512, a vaccine-based immunotherapy regimen (PrCa VBIR), in biochemical relapse (BCR) and metastatic castration-resistant prostate cancer (mCRPC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Oncolytic vaccinia virus gene modification and cytokine expression effects on tumor infection, immune response, and killing.

2021 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (2)